ProKidney Corp.

NASDAQ: PROK · Real-Time Price · USD
2.35
-0.07 (-2.89%)
At close: Aug 15, 2025, 3:46 PM

ProKidney Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
99.12M 60.65M 490.25M 20.56M
Short-Term Investments
259.17M 302.3M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
2.45M 1.38M n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
19.45M 9K 1.38M 25K
Total Current Assets
395.88M 374.15M 504.72M 27.27M
Property-Plant & Equipment
45.19M 46.41M 13.06M 12.6M
Goodwill & Intangibles
n/a n/a 213K 428K
Total Long-Term Assets
45.19M 46.41M 13.28M 13.03M
Total Assets
441.07M 420.55M 518M 40.3M
Account Payables
3.63M 5.1M 3.04M 2.83M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
765K 803K 493K 267K
Other Current Liabilities
10.69M 6.72M -493K -267K
Total Current Liabilities
36.22M 25.04M 10.87M 12.31M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
748K 568K 278K n/a
Total Long-Term Liabilities
3.22M 4.18M 2.18M 1.07M
Total Liabilities
39.44M 29.22M 13.06M 13.38M
Total Debt
3.24M 4.41M 2.4M 1.33M
Common Stock
29K 23K 24K 188.43M
Retained Earnings
-1.2B -1.14B -1.1B -161.51M
Comprehensive Income
130K 130K n/a n/a
Shareholders Equity
-994.95M -1.1B -1.1B 26.92M
Total Investments
259.17M 302.3M n/a 250.01M